![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Campione Di Sangue Per La Prova Del Marcatore Tumorale Immagine Stock - Immagine di richiesta, salute: 118795245 Campione Di Sangue Per La Prova Del Marcatore Tumorale Immagine Stock - Immagine di richiesta, salute: 118795245](https://thumbs.dreamstime.com/z/campione-di-sangue-per-la-prova-del-marcatore-tumorale-118795245.jpg)
Campione Di Sangue Per La Prova Del Marcatore Tumorale Immagine Stock - Immagine di richiesta, salute: 118795245
![Paradox CA 15–3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series | Biomarkers in Medicine Paradox CA 15–3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series | Biomarkers in Medicine](https://www.futuremedicine.com/cms/10.2217/bmm-2016-0142/asset/images/medium/figure2.gif)
Paradox CA 15–3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series | Biomarkers in Medicine
![CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram](https://www.researchgate.net/publication/318847012/figure/fig2/AS:631650916511761@1527608722402/CA15-3-tumor-marker-level-over-the-course-of-the-patients-treatment-Solid-line-CA15-3.png)
CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig2_HTML.jpg)